Nova Southeastern University Office of Academic Affairs Search NSU Site Map Nova Southeastern University
President's Faculty R & D Grant 
Committees, Councils
  and Boards
Faculty Policy Manual
NSU Scholarly Journals
Professional Journals
Prof. Memberships
Academic Policies & Procedures
Provost's Research and Scholarship Award
President's Faculty
 R & D Grant
PFRDG Application Review Process by NSU Librarians
Office of Academic Quality, Assessment, and Accreditation
Contact Us

Print this page  


With a focus on learning, we employ a range of strategies to support innovation, collaboration across centers, and university-wide discussion and decision-making


Thirteenth Annual Grant Winners 2012-2013


Neurocognitive Sequelae of HIV Infection in the Older Hispanic Adult


Karen S. Grosby, Ed.D. (CPS)
Anthony J. Silvagni, D.O., Pharm.D. (HPD-OST)

Faculty and Students

Amarilis Acevedo, Ph.D. (CPS)
Raymond Ownby, M.D., Ph.D. (HPD-OST)
Annelly Bure, M.A. (CPS)


Neurocognitive Sequelae of HIV Infection in the Older Hispanic AdultBy 2015, more than 50% of HIV+ persons in the United States (US) will be 50 years of age and older. Hispanic* elders in the US are particularly affected, as their rate of HIV/AIDS is 5 times higher than that of their non-Hispanic Caucasian counterparts. HIV affects brain structural and functional integrity, oftentimes resulting in cognitive impairment. Although the introduction of combined antiretroviral therapy has effectively improved immune function and has reduced the prevalence of HIV-associated dementia, the prevalence of other debilitating HIV-associated neurocognitive disorders remains high. Older adults are already at a higher risk of cognitive impairment than younger adults, and infection with HIV places additional neurocognitive burden on this population. Compared to their non-Hispanic Caucasian peers, older Hispanics in the US have higher rates of hypertension, stroke, diabetes, and other factors (e.g., low educational attainment) that increase the risk of neurocognitive impairment. Unfortunately, there is little research on the neurocognitive problems in HIV+ older Hispanics, and little is known about the interaction of medical and non-medical risk factors in their severity and clinical presentation. The proposed study will examine the performance of 20 HIV+ and 20 HIV- Spanish-speaking Hispanics age 50 and older on a battery of neurocognitive tests. The impact of medical (e.g., CD4 levels, viral load), socio-demographic (e.g., acculturation, English proficiency), and mood variables (e.g., depression, anxiety) on neurocognitive status will also be assessed. The primary aim of the study is to obtain pilot data on the intersection of HIV infection, neurocognitive status, and older age among HIV+ Hispanics. This information will be pivotal when applying for external funding for a more comprehensive investigation on this and related HIV+ populations. It will also be a first step in addressing health disparity issues in the assessment and treatment of HIV infection in this understudied population.